Home/Filings/4/0001562180-24-005421
4//SEC Filing

Gazzaley Adam 4

Accession 0001562180-24-005421

CIK 0001850266other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 10:28 AM ET

Size

5.7 KB

Accession

0001562180-24-005421

Insider Transaction Report

Form 4
Period: 2024-07-02
Transactions
  • Disposition from Tender

    Common Stock, par value $0.0001

    2024-07-021,089,3140 total
Footnotes (1)
  • [F1]Reflects disposition of shares of common stock (each, a "Share") of the Issuer at a price per Share of $0.4340 (the "Offer Price") pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2024, by and among the Issuer, Virtual Therapeutics Corporation, a Delaware corporation ("Parent") and Alpha Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer, effective as of July 2, 2024 (the "Effective Time") with the Issuer surviving the merger. As of the Effective Time, each Share held by the Reporting Person or his affiliates was converted into the Offer Price.

Issuer

Akili, Inc.

CIK 0001850266

Entity typeother

Related Parties

1
  • filerCIK 0001928033

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 10:28 AM ET
Size
5.7 KB